Vergoeding 2014-2018 voor ATC-subgroep J05AF : Nucleoside en nucleotide reverse-transcriptaseremmers

  • Raming voor de totale Zvw-populatie
  2014 2015 2016 2017 2018
J05AF01 Zidovudine (Retrovir ®) 76.529 54.545 47.977 43.341 33.182
J05AF02 Didanosine (Videx ®) 131.650 86.910 72.288 38.300 648
J05AF04 Stavudine (Zerit ®) 5.904 5.089 4.863 905 .
J05AF05 Lamivudine (Epivir ®) 1.086.700 825.310 723.910 592.750 525.760
J05AF06 Abacavir (Ziagen ®) 677.290 644.640 653.630 585.930 507.490
J05AF07 Tenofovirdisoproxil (Viread ®) 6.783.600 6.926.200 6.946.500 6.492.100 2.559.700
J05AF08 Adefovir (Hepsera ®) 630.270 529.460 431.190 377.140 351.560
J05AF09 Emtricitabine (Emtriva ®) 76.824 98.819 111.560 80.060 55.831
J05AF10 Entecavir (Baraclude ®) 6.257.200 6.453.400 7.099.800 7.479.200 3.441.600
J05AF11 Telbivudine (Sebivo ®) 42.474 33.261 21.624 22.045 24.703
J05AF13 Tenofoviralafenamide (Vemlidy ®) . . . 58.458 522.440
Totaal 15.768.441 15.657.634 16.113.342 15.770.229 8.022.914